Key Developments in Cancer Immunotherapy Over the Last Decade
Listicle Jun 02, 2020 | By Dr Georgia McDonald
Cancer immunotherapy has been heralded as the most promising advancement in the treatment of cancer since the discovery of chemotherapy. Immunotherapies for over a dozen types of cancer have been awarded regulatory approval, leading to a decline in the overall rate of cancer mortality in the US.
Here we discuss the seminal immunotherapies of the decade and their impact on the future of cancer therapy.
Download this list to explore:
- Current immunotherapeutic strategies
- Recent regulatory approvals
- The future of cancer therapy
Download this listicle to learn about four cellular senescence studies including the elimination of senescent cells delays tumorigenesis and extends lifespans in mice, senolytic treatment reduces plaque development and increases vasomotor function, implications in Alzheimer's disease and senolytics for kidney disease: a promising preliminary clinical report.READ MORE